IL184620A0 - Composition for the treatment of inflammation - Google Patents
Composition for the treatment of inflammationInfo
- Publication number
- IL184620A0 IL184620A0 IL184620A IL18462007A IL184620A0 IL 184620 A0 IL184620 A0 IL 184620A0 IL 184620 A IL184620 A IL 184620A IL 18462007 A IL18462007 A IL 18462007A IL 184620 A0 IL184620 A0 IL 184620A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammation
- treatment
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL184620A IL184620A0 (en) | 2007-07-15 | 2007-07-15 | Composition for the treatment of inflammation |
PCT/IL2008/000976 WO2009010967A1 (en) | 2007-07-15 | 2008-07-15 | An agent for treatment of inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL184620A IL184620A0 (en) | 2007-07-15 | 2007-07-15 | Composition for the treatment of inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL184620A0 true IL184620A0 (en) | 2008-01-20 |
Family
ID=39941836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL184620A IL184620A0 (en) | 2007-07-15 | 2007-07-15 | Composition for the treatment of inflammation |
Country Status (2)
Country | Link |
---|---|
IL (1) | IL184620A0 (en) |
WO (1) | WO2009010967A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL200753A (en) * | 2009-09-06 | 2015-06-30 | Can Fite Biopharma Ltd | Pharmaceutical composition comprising ib-meca for the treatment of psoriasis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3620674A1 (en) * | 1986-06-20 | 1987-12-23 | Nattermann A & Cie | Ointment for the treatment of skin diseases |
GB8630273D0 (en) * | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
US5583153A (en) * | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
JP2007501864A (en) * | 2003-06-11 | 2007-02-01 | ノバセア インコーポレイティッド | Treatment of immune mediated diseases by active vitamin D compounds alone or in combination with other therapeutic agents |
US20080300213A1 (en) * | 2005-11-30 | 2008-12-04 | Pnina Fishman | Use of A3 Adenosine Receptor Agonist in Osteoarthritis Treatment |
CA2622975C (en) * | 2006-01-27 | 2011-05-03 | Can-Fite Biopharma Ltd. | Adenosine a3 receptor agonists for the treatment of dry eye disorders |
-
2007
- 2007-07-15 IL IL184620A patent/IL184620A0/en unknown
-
2008
- 2008-07-15 WO PCT/IL2008/000976 patent/WO2009010967A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009010967A1 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256861A1 (en) | Compositions for the treatment of gastrointestinal inflammation | |
HRP20190059T1 (en) | Compositions for the treatment of pain and/or inflammation | |
ZA201001304B (en) | Compositions for the treatment of neoplastic diseases | |
PL1975226T3 (en) | Liquid treatment composition | |
ZA200902374B (en) | Compositions useful for the treatment of diabetes | |
GB0802403D0 (en) | Compositions for the treatment of oxidative stress | |
HK1166305A1 (en) | Compositions and methods for the treatment of inflammation | |
ZA201100653B (en) | Topical composition for the treatment of ctinic keratosis | |
IL209360A (en) | Pharmaceutical compositions comprising pm00104 for the treatment of multiple myeloma | |
IL205137A0 (en) | 5-cyanothienopyridines for the treatment of tumours | |
PL2209458T3 (en) | Skin treatment compositions | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
EP2174956A4 (en) | Compositions for anti-fibrinolitic treatment | |
IL208624A0 (en) | Compositions for the treatment of lice | |
PL2323625T3 (en) | New composition for the treatment of ecchymotic pigmentations | |
GB0723100D0 (en) | Treatment of HFnEF | |
PL2252302T3 (en) | Composition for the treatment of osteoarthritis | |
IL184620A0 (en) | Composition for the treatment of inflammation | |
GB0808326D0 (en) | Compositions and methods for the treatment of fybromyalgia | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
GB0609789D0 (en) | Treatment of inflammation | |
GB0705674D0 (en) | Composition for the treatment of halitosis | |
GB0809319D0 (en) | The treatment of puritus | |
GB0700572D0 (en) | Composition for treating dermatological conditions |